Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin?), hydrocodone (Vicodin?), codeine, morphine, and many others.
The Opioids Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Opioids Drugs industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Opioids Drugs market can be split based on product types, major applications, and important countries as follows:
Key players in the global Opioids Drugs market covered in Chapter 12:
Teva pharmaceuticals
Hospira
Allergan
Endo Pharmaceuticals
Pfizer
Johnson & Johnson
Orexo Pharmaceuticals
Sanofi-aventis US LLC
Purdue Pharma
AbbVie
In Chapter 4 and 14.1, on the basis of types, the Opioids Drugs market from 2015 to 2025 is primarily split into:
Oxycodone (e.g., OxyContin, Percocet)
Hydrocodone (e.g., Vicodin)
Codeine
Morphine (e.g., Kadian, Avinza)
Others
In Chapter 5 and 14.2, on the basis of applications, the Opioids Drugs market from 2015 to 2025 covers:
Neuropathic pain treatment
Orthopedic pain treatment
Other pain treatment
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Opioids Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Opioids Drugs
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Opioids Drugs industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Opioids Drugs Market Size, 2015 - 2020
2.1.2 Global Opioids Drugs Market Size by Type, 2015 - 2020
2.1.3 Global Opioids Drugs Market Size by Application, 2015 - 2020
2.1.4 Global Opioids Drugs Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Opioids Drugs Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Opioids Drugs Analysis
3.2 Major Players of Opioids Drugs
3.3 Opioids Drugs Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Opioids Drugs
3.3.3 Labor Cost of Opioids Drugs
3.4 Market Distributors of Opioids Drugs
3.5 Major Downstream Buyers of Opioids Drugs Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Opioids Drugs Market, by Type
4.1 Global Opioids Drugs Value and Market Share by Type (2015-2020)
4.2 Global Opioids Drugs Production and Market Share by Type (2015-2020)
4.3 Global Opioids Drugs Value and Growth Rate by Type (2015-2020)
4.3.1 Global Opioids Drugs Value and Growth Rate of Oxycodone (e.g., OxyContin, Percocet)
4.3.2 Global Opioids Drugs Value and Growth Rate of Hydrocodone (e.g., Vicodin)
4.3.3 Global Opioids Drugs Value and Growth Rate of Codeine
4.3.4 Global Opioids Drugs Value and Growth Rate of Morphine (e.g., Kadian, Avinza)
4.3.5 Global Opioids Drugs Value and Growth Rate of Others
4.4 Global Opioids Drugs Price Analysis by Type (2015-2020)
5 Opioids Drugs Market, by Application
5.1 Downstream Market Overview
5.2 Global Opioids Drugs Consumption and Market Share by Application (2015-2020)
5.3 Global Opioids Drugs Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Opioids Drugs Consumption and Growth Rate of Neuropathic pain treatment (2015-2020)
5.3.2 Global Opioids Drugs Consumption and Growth Rate of Orthopedic pain treatment (2015-2020)
5.3.3 Global Opioids Drugs Consumption and Growth Rate of Other pain treatment (2015-2020)
6 Global Opioids Drugs Market Analysis by Regions
6.1 Global Opioids Drugs Sales, Revenue and Market Share by Regions
6.1.1 Global Opioids Drugs Sales by Regions (2015-2020)
6.1.2 Global Opioids Drugs Revenue by Regions (2015-2020)
6.2 North America Opioids Drugs Sales and Growth Rate (2015-2020)
6.3 Europe Opioids Drugs Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Opioids Drugs Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Opioids Drugs Sales and Growth Rate (2015-2020)
6.6 South America Opioids Drugs Sales and Growth Rate (2015-2020)
7 North America Opioids Drugs Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Opioids Drugs Sales, Revenue and Market Share by Countries
7.2.1 North America Opioids Drugs Sales by Countries (2015-2020)
7.2.2 North America Opioids Drugs Revenue by Countries (2015-2020)
7.3 United States Opioids Drugs Sales and Growth Rate (2015-2020)
7.4 Canada Opioids Drugs Sales and Growth Rate (2015-2020)
7.5 Mexico Opioids Drugs Sales and Growth Rate (2015-2020)
8 Europe Opioids Drugs Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Opioids Drugs Sales, Revenue and Market Share by Countries
8.2.1 Europe Opioids Drugs Sales by Countries (2015-2020)
8.2.2 Europe Opioids Drugs Revenue by Countries (2015-2020)
8.3 Germany Opioids Drugs Sales and Growth Rate (2015-2020)
8.4 UK Opioids Drugs Sales and Growth Rate (2015-2020)
8.5 France Opioids Drugs Sales and Growth Rate (2015-2020)
8.6 Italy Opioids Drugs Sales and Growth Rate (2015-2020)
8.7 Spain Opioids Drugs Sales and Growth Rate (2015-2020)
8.8 Russia Opioids Drugs Sales and Growth Rate (2015-2020)
9 Asia Pacific Opioids Drugs Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Opioids Drugs Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Opioids Drugs Sales by Countries (2015-2020)
9.2.2 Asia Pacific Opioids Drugs Revenue by Countries (2015-2020)
9.3 China Opioids Drugs Sales and Growth Rate (2015-2020)
9.4 Japan Opioids Drugs Sales and Growth Rate (2015-2020)
9.5 South Korea Opioids Drugs Sales and Growth Rate (2015-2020)
9.6 India Opioids Drugs Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Opioids Drugs Sales and Growth Rate (2015-2020)
9.8 Australia Opioids Drugs Sales and Growth Rate (2015-2020)
10 Middle East and Africa Opioids Drugs Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Opioids Drugs Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Opioids Drugs Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Opioids Drugs Revenue by Countries (2015-2020)
10.3 Saudi Arabia Opioids Drugs Sales and Growth Rate (2015-2020)
10.4 UAE Opioids Drugs Sales and Growth Rate (2015-2020)
10.5 Egypt Opioids Drugs Sales and Growth Rate (2015-2020)
10.6 Nigeria Opioids Drugs Sales and Growth Rate (2015-2020)
10.7 South Africa Opioids Drugs Sales and Growth Rate (2015-2020)
11 South America Opioids Drugs Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Opioids Drugs Sales, Revenue and Market Share by Countries
11.2.1 South America Opioids Drugs Sales by Countries (2015-2020)
11.2.2 South America Opioids Drugs Revenue by Countries (2015-2020)
11.3 Brazil Opioids Drugs Sales and Growth Rate (2015-2020)
11.4 Argentina Opioids Drugs Sales and Growth Rate (2015-2020)
11.5 Columbia Opioids Drugs Sales and Growth Rate (2015-2020)
11.6 Chile Opioids Drugs Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Teva pharmaceuticals
12.1.1 Teva pharmaceuticals Basic Information
12.1.2 Opioids Drugs Product Introduction
12.1.3 Teva pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.2 Hospira
12.2.1 Hospira Basic Information
12.2.2 Opioids Drugs Product Introduction
12.2.3 Hospira Production, Value, Price, Gross Margin 2015-2020
12.3 Allergan
12.3.1 Allergan Basic Information
12.3.2 Opioids Drugs Product Introduction
12.3.3 Allergan Production, Value, Price, Gross Margin 2015-2020
12.4 Endo Pharmaceuticals
12.4.1 Endo Pharmaceuticals Basic Information
12.4.2 Opioids Drugs Product Introduction
12.4.3 Endo Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 Pfizer
12.5.1 Pfizer Basic Information
12.5.2 Opioids Drugs Product Introduction
12.5.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Basic Information
12.6.2 Opioids Drugs Product Introduction
12.6.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.7 Orexo Pharmaceuticals
12.7.1 Orexo Pharmaceuticals Basic Information
12.7.2 Opioids Drugs Product Introduction
12.7.3 Orexo Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.8 Sanofi-aventis US LLC
12.8.1 Sanofi-aventis US LLC Basic Information
12.8.2 Opioids Drugs Product Introduction
12.8.3 Sanofi-aventis US LLC Production, Value, Price, Gross Margin 2015-2020
12.9 Purdue Pharma
12.9.1 Purdue Pharma Basic Information
12.9.2 Opioids Drugs Product Introduction
12.9.3 Purdue Pharma Production, Value, Price, Gross Margin 2015-2020
12.10 AbbVie
12.10.1 AbbVie Basic Information
12.10.2 Opioids Drugs Product Introduction
12.10.3 AbbVie Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Opioids Drugs Market Forecast
14.1 Global Opioids Drugs Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Oxycodone (e.g., OxyContin, Percocet) Market Value and Volume Forecast (2020-2025)
14.1.2 Hydrocodone (e.g., Vicodin) Market Value and Volume Forecast (2020-2025)
14.1.3 Codeine Market Value and Volume Forecast (2020-2025)
14.1.4 Morphine (e.g., Kadian, Avinza) Market Value and Volume Forecast (2020-2025)
14.1.5 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Opioids Drugs Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Neuropathic pain treatment Market Value and Volume Forecast (2020-2025)
14.2.2 Orthopedic pain treatment Market Value and Volume Forecast (2020-2025)
14.2.3 Other pain treatment Market Value and Volume Forecast (2020-2025)
14.3 Opioids Drugs Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter